Orbits Oncology
PrivateLast Round
Accelerator
Feb 27, 2025
Total Funding Raised
$250,000
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Orbits Oncology operates in Healthcare & Life Sciences and is based in San Francisco, California. Its latest recorded funding round was an Accelerator round in February 2025.
Orbits Oncology is a biotechnology company that develops a cloud-based, AI-powered image analysis and drug screening platform designed to help cancer researchers make decisions in drug development.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Precision Medicine, Medical Imaging, Healthcare Analytics, Biotechnology
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Orbits Oncology Comparables
Compare Orbits Oncology with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ProxyBio | 82% | |
| QuantaCell | 78% | |
| Orakl Oncology | 70% |
For institutional investors. Book with your work email.
Orbits Oncology Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Feb 27, 2025 | ||||
| Accelerator | Aug 6, 2024 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Orbits Oncology Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| AlphaLab | Accelerator |
| Northpond Ventures | Accelerator |
| McKesson Ventures | Accelerator |
| Innovation Works | Accelerator |
| Merck Digital Sciences Studio | Accelerator |
| New Jersey Innovation Institute | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors increased 96% MoM.
- May 17, 2026
Monthly visitors increased 267% MoM.
For institutional investors. Book with your work email.
Orbits Oncology Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Orbits Oncology's valuation, stock price, and market status.
Is Orbits Oncology a public or private company?
Orbits Oncology is a private company.
What is the current stock price of Orbits Oncology?
Orbits Oncology is a private company, so its shares have no public market price. Caplight tracks Orbits Oncology's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Orbits Oncology worth (valuation)?
Valuation information for Orbits Oncology is not publicly available.
Can I buy Orbits Oncology stock?
Orbits Oncology shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Orbits Oncology's last funding round?
Orbits Oncology's most recent funding round was Accelerator on February 27, 2025.
Who are the main investors in Orbits Oncology?
Key investors in Orbits Oncology include AlphaLab, Northpond Ventures, McKesson Ventures, Innovation Works, Merck Digital Sciences Studio.
Will Orbits Oncology IPO soon?
No public IPO plans have been announced for Orbits Oncology.
How can I track Orbits Oncology secondary market activity?
Caplight tracks bids, offers, and trades in Orbits Oncology's shares on secondary markets.